Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Aquaculture Vaccines Market

Aquaculture Vaccines Market Size

Report ID: GMI3323
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Aquaculture Vaccines Market Size

The global aquaculture vaccines market size was valued at USD 407.4 million in 2024 and is estimated to grow at a CAGR of 8% from 2025 to 2034. The growth of the market is driven by the increasing global demand for seafood and the need for sustainable aquaculture practices.

To get key market trends

Download Free Sample

As fish farming expands to meet dietary needs, the industry faces challenges such as disease outbreaks that can significantly impact productivity and profitability. Vaccination has emerged as a critical preventive measure to reduce reliance on antibiotics and minimize losses due to infectious diseases. Regulatory authorities and governments worldwide are promoting vaccination programs to ensure the health and welfare of farmed fish, further bolstering market growth.

Aquaculture Vaccines Market Report Attributes
Report Attribute	Details
Base Year:	2024
Aquaculture Vaccines Market Size in 2024:	USD 407.4 Million
Forecast Period:	2025 - 2034
Forecast Period 2025 - 2034 CAGR:	8%
2034 Value Projection:	USD 862.8 Million
Historical Data for:	2021 - 2023
No. of Pages:	135
Tables, Charts & Figures:	102
Segments covered:	Vaccine Type, Route of Administration, Application, Species, and Region
Growth Drivers:	Surging prevalence of bacterial and viral infections Increasing aquaculture production across the globe Development and launch of new aquaculture vaccines Rising adoption of aquaculture vaccines over antibiotics
Pitfalls & Challenges:	Stringent regulatory policies for vaccine approval Complex vaccine development procedures

Learn more about the key segments shaping this market

Download Free Sample

Additionally, advancement in vaccine development technologies, including recombinant DNA and subunit vaccines, which enhance efficacy and reduce side effects, further boost the market growth. Moreover, the expansion of aquaculture in developing regions, where governments are investing in modern farming infrastructure, is expected to create new opportunities for vaccine manufacturers.

Aquaculture vaccines are biological preparations used to prevent and control infectious diseases in aquatic animals within the aquaculture industry. These vaccines help improve animal health, enhance production efficiency, and reduce the reliance on antibiotics, which supports sustainable aquaculture practices.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global aquaculture vaccines industry was valued at USD 407.4 million in 2024 and is estimated to grow at a CAGR of 8% from 2025 to 2034, driven by increasing global demand for seafood and sustainable aquaculture practices.

The inactivated vaccine segment was valued at USD 302.6 million in 2024, holding a significant market share due to its proven safety and efficacy in protecting fish populations against various bacterial and viral diseases.

The European region dominates the aquaculture vaccines industry, with Norway's market valued at USD 85.4 million in 2024, driven by its robust aquaculture industry, particularly in salmon farming.

Key players in the sector include CIBA, HIPRA, Kyoto Biken Laboratories, Kemin Industries, Kyoritsuseiyaku Corporation, Merck Animal Health (a division of Merck & Co.), Nisseiken, Phibro Animal Health Corporation, Tecnovax, Virbac, and Veterquimica.